Nanox Vision

Company Overview

Snapshot

Founded in December 2018, Nanox Vision operates with 51–200 employees and has raised a total of $345 million across 7 funding rounds from 6 investors. The company went public on NASDAQ in August 2020, achieving a valuation of $1.2 billion.

Business overview

Nanox Vision is a Health Tech & Life Sciences company focused on advancing preventive healthcare through innovative medical imaging technologies. The company develops a comprehensive ecosystem that includes Nanox.ARC, a cost-effective multi-source Digital Tomosynthesis system; Nanox.AI, an AI-based suite of algorithms for early detection of chronic diseases from CT scans; and Nanox.CLOUD, a cloud-based platform for data management and imaging analysis. Nanox also operates Nanox.MARKETPLACE, a decentralized platform providing remote access to radiology and cardiology experts, aiming to deliver seamless, end-to-end solutions from scan to diagnosis and improve health outcomes globally.

Strategic signal

In November 2025, Nanox.AI's Bone Solutions, an advanced AI-powered software for spine assessment, received a recommendation from NICE for Early Value Assessment in UK National Health Service hospitals. This signals significant market validation and potential for broader adoption of Nanox's AI diagnostic tools within major healthcare systems, indicating a strong forward trajectory for its AI-driven solutions.

Company Intelligence Q&A

What was a significant recent partnership for Nanox Vision?

In September 2025, Nanox Vision partnered with Monarch Medical Management in a multi-segment healthcare collaboration to expand access to advanced 3D imaging and other medical imaging solutions.

What is the latest development regarding Nanox.AI's Bone Solutions?

In November 2025, Nanox.AI's Bone Solutions, an advanced AI-powered software for spine assessment, was recommended by NICE for Early Value Assessment in UK National Health Service hospitals.

When did Nanox Vision go public?

Nanox Vision went public on NASDAQ in August 2020, with an initial public offering that valued the company at $1.2 billion.

What was a key strategic manufacturing agreement for Nanox Vision?

In October 2023, Nanox Vision announced a strategic manufacturing agreement with Varex Imaging Corporation to advance the Nanox.ARC Medical Imaging System.

What was a notable early agreement for the deployment of Nanox.ARC units?

In September 2020, Nanox Vision signed an agreement with SPI Medical for the deployment of 630 Nanox.ARC units in Mexico.